A187420 Stock Overview
GenoFocus, Inc. engages in the research and development, production, sales, and import/export of enzymes and fermentation products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
GenoFocus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,215.00 |
| 52 Week High | ₩6,150.00 |
| 52 Week Low | ₩2,800.00 |
| Beta | 0.52 |
| 1 Month Change | -4.20% |
| 3 Month Change | 4.98% |
| 1 Year Change | -6.33% |
| 3 Year Change | -58.68% |
| 5 Year Change | -41.70% |
| Change since IPO | -66.68% |
Recent News & Updates
Is GenoFocus (KOSDAQ:187420) A Risky Investment?
Apr 13
Can You Imagine How GenoFocus' (KOSDAQ:187420) Shareholders Feel About The 55% Share Price Increase?
Feb 16Is GenoFocus (KOSDAQ:187420) A Risky Investment?
Dec 22Shareholder Returns
| A187420 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | 10.9% | 1.8% | 3.4% |
| 1Y | -6.3% | -25.6% | 7.1% |
Return vs Industry: A187420 exceeded the KR Chemicals industry which returned -28% over the past year.
Return vs Market: A187420 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A187420 volatility | |
|---|---|
| A187420 Average Weekly Movement | 6.3% |
| Chemicals Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A187420 has not had significant price volatility in the past 3 months.
Volatility Over Time: A187420's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 66 | Eui-Joong Kim | www.genofocus.com |
GenoFocus, Inc. engages in the research and development, production, sales, and import/export of enzymes and fermentation products in South Korea and internationally. Its products include industrial special enzyme including lactase intended for prevention of pathogen infection/proliferation and food poisoning, and prevention of allergies and atopy; proteinase K, a recombinant serine protease secreted from the fungal strain, Tritirachium album used for isolation of pure DNA from cultured cells and tissues, removal of DNase and RNase to isolate DNA and RNA from cells and tissues, and increase PRC cloning efficiency; and catalase, a hydrogen peroxide decomposing enzyme used in semiconductor water treatment, textile process, HPPO manufacturing process, etc. The company also offers bio-health care ingredient, such as N-phytosphingosine, a cosmetic material to help improve skin barrier function; and vitamin K2 for bone and cardiovascular health benefits. In addition, the company is developing superoxide dismutase, an antioxidant enzyme that is in preclinical trial.
GenoFocus, Inc. Fundamentals Summary
| A187420 fundamental statistics | |
|---|---|
| Market cap | ₩95.93b |
| Earnings (TTM) | -₩2.95b |
| Revenue (TTM) | ₩27.01b |
3.6x
P/S Ratio-32.5x
P/E RatioIs A187420 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A187420 income statement (TTM) | |
|---|---|
| Revenue | ₩27.01b |
| Cost of Revenue | ₩19.68b |
| Gross Profit | ₩7.33b |
| Other Expenses | ₩10.28b |
| Earnings | -₩2.95b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -129.63 |
| Gross Margin | 27.14% |
| Net Profit Margin | -10.92% |
| Debt/Equity Ratio | 210.3% |
How did A187420 perform over the long term?
See historical performance and comparison